Article
Advances in the design and delivery of RNA vaccines for infectious diseases
5 Aug 2024
Abstract excerpt
RNA medicines represent a paradigm shift in treatment and prevention of critical diseases of global significance, e.g., infectious diseases. The highly successful messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed at record speed during the coronavirus disease 2019 pandemic. A consequence of this is exceptionally shortened vaccine development times,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
